Common painkiller tested as cancer shield
NCT ID NCT02394769
Summary
This study is testing whether taking a daily aspirin pill can help prevent colorectal cancer in people who are at higher risk because they've had precancerous polyps removed. Researchers are comparing a low-dose aspirin, a regular-dose aspirin, and a placebo (sugar pill) in 180 adults. They will measure changes in various body fluids and tissues over time to see if aspirin has a protective effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.